Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 5/20 | 0.38 |
| ▸ | BCAT2 | O15382 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MET | P08581 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3850293 | 0.92 | BCAT1 (0.39) | BCAT1BCAT2LMNAPOLBTSHR | |
| SCHEMBL4572166 | 0.90 | UGCG (0.36) | BCAT1BCAT2METDHODH | |
| SCHEMBL27044947 | 0.86 | BCAT1 (0.39) | BCAT1BCAT2LMNAPOLBMEN1 | |
| SCHEMBL3245244 | 0.86 | BCAT1 (0.39) | BCAT1BCAT2LMNAPOLBTSHR | |
| SCHEMBL29452779 | 0.86 | BCAT1 (0.39) | BCAT1BCAT2LMNAPOLBTSHR | |
| SCHEMBL25291362 | 0.86 | PPOX (0.37) | BCAT1BCAT2LMNAMAPTMEN1 | |
| SCHEMBL13843249 | 0.85 | PPOX (0.46) | BCAT1BCAT2LMNAMAPTKDM4E | |
| SCHEMBL13842952 | 0.85 | ALDH1A1 (0.43) | BCAT1BCAT2LMNAKDM4ETSHR | |
| SCHEMBL27044937 | 0.84 | BCAT1 (0.35) | BCAT1BCAT2LMNAMAPTKDM4E | |
| SCHEMBL30792811 | 0.84 | BCAT1 (0.35) | BCAT1BCAT2LMNAMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8293979-B2 | Weed controller metabolism proteins, genes, thereof and use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-23 | — | — | US | disclosed |
| EP-2453018-A1 | A herbicide metabolizing protein, a gene thereof and use thereof | Sumitomo Chemical Company, Limited (JP) | 2012-05-16 | — | — | EP | disclosed |
| US-20100313300-A1 | WEED CONTROLLER METABOLISM PROTEINS, GENES, THEREOF AND USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED | 2010-12-09 | — | — | US | disclosed |
| US-7745699-B2 | Weed controller metabolism proteins, genes thereof and use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100313300-A1 | WEED CONTROLLER METABOLISM PROTEINS, GENES, THEREOF AND USE OF THE SAME | HADHB, WEE1, AS3MT | BCAT1 166/4885BCAT2 337/4885LMNA 4368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.